Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Sept 2019 for Novelion Therapeutics Inc., €2,045. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Michael Price: trading record in brief
This profile gathers the share dealings of Michael Price in Novelion Therapeutics Inc. We count 5 filings; the first trade dates from 4 December 2017 and the latest from 24 September 2019.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 27 September 2019: a transaction of €2,045, in Novelion Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Price
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,926 shares@ CA$0.7614.3% of flowCommon SharesTSXSEDI:3429802
13,333 shares@ CA$0.7648.7% of flowCommon SharesTSXSEDI:3429808
1,963 shares@ CA$0.91998.4% of flowCommon SharesTSXSEDI:3270607
6,667 shares@ CA$0.919928.6% of flowCommon SharesTSXSEDI:3270606
Common SharesTSXSEDI:3270600
5 of 5 declarations
